Clinical trials
Ovarian Mass clinical trials
Below are recruiting ovarian mass clinical trials, each written for real people, not researchers. We’re tracking 14 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06638593Recruiting
Comparing open vs. robotic surgery for pelvic masses up to 8cm
This study compares two types of minimally invasive surgery—traditional laparoscopic (keyhole) versus robotic-assisted—for removing complex ovarian cysts or masses up to 8cm that haven't spread. The goal is to see which approach might offer better recovery and outcomes for women with these growths.
GuildfordAges 18–100 - NCT06566716Recruiting
Blood test to check for cancer risk before ovarian mass surgery
This study tests a new blood test to help doctors determine if an ovarian mass is cancerous before surgery. If you are a woman over 18 with an ovarian cyst or mass that needs surgery, this test could help guide your care.
Chandler, ArizonaAges 18 years+ - NCT02425540Recruiting
MRI with special images to sort unclear ovarian masses
This study uses pelvic MRI with special techniques (including blood-flow and water-movement pictures) to better classify ovarian/adnexal masses that ultrasound cannot clearly explain. It may help doctors choose the safest next steps based on more detailed imaging.
Leuven, Vlaams-BrabantAges Any age - NCT06473766Recruiting
Ultrasound data to tell benign from malignant ovarian masses
This study uses ultrasound data to help tell the difference between benign (non-cancerous) and malignant (cancerous) solid ovarian masses. It may help improve diagnosis and treatment decisions for people with this condition.
RomaAges 18 years+ - NCT06635837Recruiting
MRI for ovarian masses during pregnancy
This study looks at whether MRI can help doctors better understand ovarian masses found during pregnancy. It aims to improve diagnosis and care for you and your baby.
RomeAges 18 years+ - NCT07313514Recruiting
Predicting ovarian mass risk in girls under 16
This study looks at whether a special scoring system (O-RADS) on MRI scans can help doctors tell if an ovarian mass is cancer or not before surgery. It aims to improve diagnosis and treatment planning for young girls.
StrasbourgAges 1–16 - NCT05842629Recruiting
Better ways to diagnose ovarian cancer
This study focuses on improving diagnosis of ovarian cancer. If you have an abnormal mass seen on ultrasound near the ovaries, the researchers may evaluate how best to identify whether it could be ovarian cancer.
AarhusAges Any age - NCT05051722Recruiting
Test DNA blood and tissue markers to detect gynecologic cancers
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
Phoenix, ArizonaAges 18 years+ - NCT06556342Recruiting
Testing a new contrast agent for ovarian mass ultrasound
This trial is testing an investigational contrast agent (FRD001) to see if it improves ultrasound images of suspicious ovarian masses. The goal is to help doctors better tell if a mass is cancerous or not.
Wuhan, HubeiAges 18–75 - NCT05610501Recruiting
Ultrasound-guided biopsy for pelvic masses
This study looks at how well an ultrasound-guided needle biopsy (Tru-Cut) can safely collect tissue samples from pelvic masses. It may help doctors confirm diagnoses and guide treatment by improving how biopsies are done in real-world care.
LeuvenAges 18 years+ - NCT06693596Recruiting
Ovarian mass study for girls and teens up to age 20
This study collects information on ovarian masses in young patients to improve diagnosis. If you are 20 or younger and have a newly found mass on an ovary, you may join to help researchers learn more about these growths.
LeuvenAges birth–20 years - NCT05974618Recruiting
Testing an ultrasound model to sort pregnancy ovarian cysts
This study checks how well a specific ultrasound-based scoring tool can tell the difference between harmless (non-cancer) and harmful (cancer) ovarian masses during pregnancy. If you have a cyst or mass that’s at least 5 cm, your scan details may be used to validate the tool.
Leuven, Vlaams-BrabantAges 18–50 - NCT07078409Enrolling by invitation
Screening for ovarian cancer risk
This trial tests whether a nudge or reminder can help doctors refer patients with suspicious ovarian masses to a gynecologic oncologist. If you have a finding on an imaging test that suggests possible ovarian cancer, this study may help connect you with the right specialist.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07740759Enrolling by invitation
Educational videos for pre-surgery anxiety
This trial tests whether watching educational videos before your laparoscopic surgery helps reduce anxiety. It may help you feel more prepared and calm before your procedure.
Farmington, ConnecticutAges 18 years+
Hear when a new Ovarian Mass trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ovarian mass?
- Yes. Clin2 currently lists 14 recruiting ovarian mass studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ovarian mass trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ovarian mass trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.